GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

SLM · Mar 31, 2026

SLM Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001032033-26-000025Bank
Sequential deposit growth25thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-2.54% · CORE · VALID

Net-income growth45thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

1.12% · CORE · VALID

Interest-income growth25thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

-1.03% · CORE · VALID

Cash and equivalents90thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$5.2B · CORE · VALID

Sequential loan growth30thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

-2.19% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History43 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
5.24%
Current
-2.54%
Delta
-7.78%
Earnings Growth Decreased
Previous
22.44%
Current
1.12%
Delta
-21.32%
Interest Income Growth Decreased
Previous
0.31%
Current
-1.03%
Delta
-1.35%
Liquidity Increased
Previous
$4.2B
Current
$5.2B
Delta
$916.2M
Loan Growth Increased
Previous
-5.94%
Current
-2.19%
Delta
3.74%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.